MENU
+Compare
ALKS
Stock ticker: NASDAQ
AS OF
Apr 8 closing price
Price
$28.19
Change
-$1.30 (-4.41%)
Capitalization
4.55B

ALKS Alkermes plc Forecast, Technical & Fundamental Analysis

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ALKS with price predictions
Apr 08, 2025

ALKS in upward trend: price may ascend as a result of having broken its lower Bollinger Band on April 03, 2025

ALKS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where ALKS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALKS advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALKS as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ALKS moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ALKS crossed bearishly below the 50-day moving average on April 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALKS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ALKS entered a downward trend on April 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALKS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.784) is normal, around the industry mean (61.171). P/E Ratio (8.902) is within average values for comparable stocks, (90.174). ALKS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (2.779) is also within normal values, averaging (20.123).

View a ticker or compare two or three
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALKS is expected to report earnings to fall 70.35% to 31 cents per share on April 23

Alkermes plc ALKS Stock Earnings Reports
Q1'25
Est.
$0.31
Q4'24
Beat
by $0.30
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.04
Q1'24
Missed
by $0.16
The last earnings report on February 12 showed earnings per share of $1.05, beating the estimate of 75 cents. With 2.04M shares outstanding, the current market capitalization sits at 4.55B.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2100
Web
https://www.alkermes.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DEEF27.66N/A
+0.01%
Xtrackers FTSE Develop ex US Mulfact ETF
FLDZ26.76N/A
N/A
RiverNorth Patriot ETF
IXG90.79-0.10
-0.11%
iShares Global Financials ETF
DBAW31.30-0.20
-0.63%
Xtrackers MSCI All World exUS Hdg Eq ETF
DSTL48.53-0.80
-1.61%
Distillate US Fdmtl Stblty & Val ETF

ALKS and Stocks

Correlation & Price change

A.I.dvisor tells us that ALKS and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALKS and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-4.41%
ACET - ALKS
30%
Poorly correlated
-3.24%
ESPR - ALKS
28%
Poorly correlated
-11.67%
DVAX - ALKS
27%
Poorly correlated
-5.92%
PRGO - ALKS
27%
Poorly correlated
-5.72%
ZTS - ALKS
25%
Poorly correlated
-3.15%
More